Literature DB >> 9408703

Fertility regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and Copper T 380-A intrauterine devices.

S Díaz1, A Zepeda, X Maturana, M V Reyes, P Miranda, M E Casado, O Peralta, H B Croxatto.   

Abstract

This study evaluated the performance of progesterone vaginal rings (n = 187), progestin-only pills (n = 117), Norplant implants (n = 120), and Copper T 380-A intrauterine devices (n = 122) in lactating women. Contraceptive efficacy, bleeding pattern, and influence of the method upon breastfeeding duration and infant growth were compared with those of untreated women (n = 236) who relied on lactational infertility. Participants were healthy, 18 to 38 years, had had a normal delivery, and were intending to breastfeed for as long as possible. Contraceptives were initiated at day 57 +/- 3 postpartum. Results are reported for the first year of use. All methods were highly effective, with pregnancy rates below 1%. None affected breastfeeding performance or the rate of infant growth. Users of the progestin-only methods experienced a period of lactational amenorrhea 4 to 5 months longer than did users of Copper T or untreated women. More than half of the women in each contraceptive group reported a bleeding in the first month after treatment initiation, which was not considered in the calculation of the duration of amenorrhea. Prolonged or frequent bleedings were infrequent. The proportion of bleedings lasting more than 10 days ranged from 0 in the progestin-only pills group to 7% in the Norplant implants group. The four methods, initiated around the eighth postpartum week, provided effective contraception with no negative effects upon lactation or infant growth and without the bleeding problems associated with their use in nonlactating women.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9408703     DOI: 10.1016/s0010-7824(97)00135-2

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  4 in total

1.  Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India.

Authors:  Malabika Roy; Avishek Hazra; Ruth Merkatz; Marlena Plagianos; Mohcine Alami; L N Gaur; Kumudha Aruldas; Heather Sussman; Bruce Variano; Regine Sitruk-Ware
Journal:  Contraception       Date:  2020-05-01       Impact factor: 3.375

2.  Impact of injectable progestogen contraception in early puerperium on lactation and infant health.

Authors:  Seema Singhal; Nivedita Sarda; Shipra Gupta; Sakshi Goel
Journal:  J Clin Diagn Res       Date:  2014-03-15

3.  The optimization of an intravaginal ring releasing progesterone using a mathematical model.

Authors:  Ignacio M Helbling; Juan C D Ibarra; Julio A Luna
Journal:  Pharm Res       Date:  2013-10-18       Impact factor: 4.200

Review 4.  Priority strategies for India's family planning programme.

Authors:  Saroj Pachauri
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.